{"id":"dmb-i-inn-latrepirdine","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Latrepirdine acts as a mitochondrial neuroprotectant by stabilizing mitochondrial membrane potential and reducing reactive oxygen species production. It also antagonizes NMDA receptors and inhibits monoamine oxidases, providing multi-target neuroprotection against excitotoxic and oxidative stress-induced neuronal damage.","oneSentence":"Latrepirdine is a neuroprotective agent that modulates mitochondrial function and reduces neuronal excitotoxicity through multiple pathways including NMDA receptor antagonism and monoamine oxidase inhibition.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:09:41.130Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Alzheimer's disease"},{"name":"Mild to moderate cognitive impairment"}]},"trialDetails":[{"nctId":"NCT07251023","phase":"PHASE3","title":"Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia","status":"RECRUITING","sponsor":"Bigespas LTD","startDate":"2025-11-20","conditions":"Alzheimer Type Dementia","enrollment":450}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Latrepirdine, Dimebon®"],"phase":"phase_3","status":"active","brandName":"DMB-I (INN: Latrepirdine)","genericName":"DMB-I (INN: Latrepirdine)","companyName":"Bigespas LTD","companyId":"bigespas-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Latrepirdine is a neuroprotective agent that modulates mitochondrial function and reduces neuronal excitotoxicity through multiple pathways including NMDA receptor antagonism and monoamine oxidase inhibition. Used for Alzheimer's disease, Mild to moderate cognitive impairment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}